Daunorubicinol-13C,d3 (mixture of diastereomers)
CAS: 28008-55-1
Ref. TR-D194512
| 1mg | 7,970.00 € | ||
| 100µg | 1,100.00 € | ||
| 2500µg | 16,031.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Product Information
Name:
Daunorubicinol-13C,d3 (mixture of diastereomers)
Controlled Product
Synonyms:
- (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[1-hydroxyethyl]-1-(methoxy-13C,d3)-5,12-naphthacenedione
- 13-Dihydrodaunorubicin-13C,d3
- Duborimycin-13C,d3
- Leukaemomycin D-13C,d3
Description:
Applications A metabolite of Daunorubicin. Used as an antineoplastic. Complexes with DNA. Inhibits DNA and RNA synthesis.
References Mizuno, N.S., et al.: Cancer Res., 35, 1542 (1975), Munger, C., et al.: Cancer Res., 48, 2404 (1988), Kobayashi, Y., et al.: J. Biol. Chem., 275, 17639 ( 2000), Burke, B., et al.: Cardiovasc. Toxicol., 2, 41 (2002),
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
533.55
Formula:
CC26D3H28NO10
Color/Form:
Neat
InChI:
InChI=1S/C27H31NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10-11,14,16-17,22,29-30,32,34-35H,7-9,28H2,1-3H3/t10-,11?,14-,16-,17-,22+,27-/m0/s1/i3+1D3
InChI key:
InChIKey=HJEZFVLKJYFNQW-ZLLBQUENSA-N
SMILES:
[2H][13C]([2H])([2H])Oc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)([C@@H](C)O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-D194512 Daunorubicinol-13C,d3 (mixture of diastereomers)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
